Abstract
Aim:
To investigate the influence of dosage forms on the pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in Wistar rats.
Methods:
After administration of two typical dosage forms (daidzein solution and suspension), the concentrations of daidzein and daidzein-7-O-glucuronide were determined by an LC-MS-MS method. The pharmacokinetic parameters were calculated and analyzed statistically using the Student's t-test.
Results:
Absorption of daidzein after administration of daidzein solution (tmax= 0.46 h) was more rapid than that of the suspension (tmax= 5.00 h). The peak plasma concentrations of daidzein after administration of daidzein solution and suspension were 601.1 μg/L and 127.3 μg/L, respectively, and those of daidzein-7-O-glucuronide were 3000 μg/L and 192.6 μg/L, respectively. The absolute bioavailabilities of free daidzein in rats after administration of daidzein solution and suspension were 12.8% and 6.1%, respectively, which were calculated to be 47.0% and 12.2%, respectively, in the form of total daidzein (free plus conjugated daidzein).
Conclusion:
Absorption of daidzein solution was better than absorption of suspension (P<0.05).
Similar content being viewed by others
Article PDF
References
Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE . Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 1994; 15: 1049–54.
Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC . Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999; 2: 489–504.
Cassidy A, Bingham S, Setchell KD . Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of pre-menopausal women. J Clin Nutr 1994; 60: 333–40.
Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, et al. Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B 2001; 760: 191–205.
Yasuda T, Kano Y, Saito K, Ohsawa K . Urinary and bilary metabolites of daidzin and daidzein in rats. Biol Pharm Bull 1994; 17: 1369–74.
Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 2002; 76: 1126–37.
Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr. 2002; 75: 126–36.
Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BF, Valentine JL, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer 2004; 48: 160–70.
Setchell KD, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, Wolfe BE, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 2003; 77: 411–9.
Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, et al. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 1998; 128: 1710–5.
Chen XY, Qiu F, Zhong DF, Duan XT, Liu CX . Validated liquid chromatography-tandem mass spectrometric method for the quantitative determination of daidzein and its main metabolite daidzein-7-O-glucuronide in rat plasma. Pharmazie 2005; 60: 334–8.
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, et al. Bioanalytical method validation: A revisit with a decade of progress. Pharm Res 2000; 17: 1551–7.
Wojcicki J, Gawronska-Szklarz B, Bieganowski W, Patalan M, Smulski HK, Samochowiec L, et al. Comparative pharmacokinetics and bioavailability of flavonoid glycosides of Ginkgo biloba after a single oral administration of three formulations to healthy volunteers. Mater Med Pol 1995; 27: 141–6.
Author information
Authors and Affiliations
Additional information
Project supported by the National Natural Science Foundation of China (No 30271525).
Rights and permissions
About this article
Cite this article
Qiu, F., Chen, Xy., Song, B. et al. Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats. Acta Pharmacol Sin 26, 1145–1152 (2005). https://doi.org/10.1111/j.1745-7254.2005.00187.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00187.x